Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

NCT01339039 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Low accrual rate

Conditions

High Grade Glioma: Glioblastoma (GBM)
High Grade Glioma: Gliosarcoma
Anaplastic Astrocytoma (AA)
Anaplastic Oligodendroglioma (AO)
Mixed Anaplastic Oligoastrocytoma (AOA)

Interventions

DRUG: Plerixafor
DRUG: Plerixafor
DRUG: Bevacizumab
DRUG: Plerixafor
PROCEDURE: Surgery

Sponsor

Patrick Y. Wen, MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]